TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $67,000 | +179.2% | 895 | 0.0% | 0.05% | +237.5% |
| Q1 2022 | $24,000 | -44.2% | 895 | 0.0% | 0.02% | -40.7% |
| Q4 2021 | $43,000 | -41.9% | 895 | -19.7% | 0.03% | -50.0% |
| Q3 2021 | $74,000 | +21.3% | 1,114 | +41.4% | 0.05% | +20.0% |
| Q2 2021 | $61,000 | +1425.0% | 788 | +1732.6% | 0.04% | +1400.0% |
| Q1 2021 | $4,000 | -50.0% | 43 | -34.8% | 0.00% | -57.1% |
| Q4 2020 | $8,000 | -76.5% | 66 | -83.2% | 0.01% | -77.4% |
| Q3 2020 | $34,000 | +580.0% | 393 | +417.1% | 0.03% | +520.0% |
| Q2 2020 | $5,000 | – | 76 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |